ライフサイエンスコーパス: multivisceral transplantation

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します

1 sirolimus-associated PRES in the setting of multivisceral transplantation.

2 osure in both adults and pediatric liver and multivisceral transplantation.

3 15/11) obtained from recipients after SBT or multivisceral transplantation.

4 s now a common practice after intestinal and multivisceral transplantation.

5 hirty-seven patients underwent intestinal or multivisceral transplantation.

6 s (Tac) immunosuppression for intestinal and multivisceral transplantation.

7 unresponsive to all therapies, we performed multivisceral transplantation.

8 Three patients with MMIHS underwent multivisceral transplantation.

9 patients continue to be considered for liver/multivisceral transplantation.

10 with worse clinical outcomes after intestine/multivisceral transplantation.

11 . 25%, combined liver and SBTx=100% vs. 30%, multivisceral transplantation=25% vs. 50%.

12 This new modification of multivisceral transplantation allows pancreaticosplenic

13 ential complications after isolated bowel or multivisceral transplantation and long-term graft surviv

14 Small intestinal allografts in multivisceral transplantation are felt to be more suscep

15 l hemitransposition, portal arterialization, multivisceral transplantation) are associated with subop

16 The patient underwent a multivisceral transplantation as a life-saving procedure

17 ysis of 98 consecutive patients who received multivisceral transplantation at our institution.

18 Multivisceral transplantation can be valuable for the tr

19 Intestinal and multivisceral transplantation could be considered in pat

20 Multivisceral transplantation cured the patient's underl

21 ld woman with short bowel syndrome underwent multivisceral transplantation due to total parenteral nu

22 only one report in the literature mentioning multivisceral transplantation for a patient with life-th

23 his is the first report in the literature of multivisceral transplantation for MMIHS.

24 A common requirement of multivisceral transplantation has been removal of the na

25 Multivisceral transplantation has recently evolved to be

26 Our case reports suggest that multivisceral transplantation is a valuable therapeutic

27 urgery applying techniques of deceased donor multivisceral transplantation is feasible in achieving l

28 Multivisceral transplantation is now an effective treatm

29 and contour in children undergoing bowel and multivisceral transplantation is often challenging due t

30 Liver-sparing "modified" multivisceral transplantation (MMVTx) has recently been

31 t (SOT) group (n = 15; 12 ITX and 3 modified multivisceral transplantation [MMVTX]) and the SOT-AWTX

32 Outcomes evaluated included need for liver/multivisceral transplantation, mortality, and the clinic

33 of isolated intestinal transplantation (IIT)/multivisceral transplantation (MVT) are among those at t

34 Multivisceral transplantation (MVtx) involves simultaneo

35 this study was to summarize the evolution of multivisceral transplantation over a decade of experienc

36 One multivisceral transplantation patient underwent isolated

37 In this cohort of small bowel/multivisceral transplantation patients, there was a high

38 3 isolated intestinal transplantation and 9 multivisceral transplantation patients.

39 We believe that multivisceral transplantation should be considered as a

40 Multivisceral transplantation should be considered as a

41 ience with three patients with MMIHS in whom multivisceral transplantation was performed.

42 Early experience with intestinal and multivisceral transplantation was plagued with high risk

43 In 2001, indications for multivisceral transplantation were expanded, and inducti

44 designed a new approach and have performed a multivisceral transplantation with splenopancreatic pres

WebLSDに未収録の専門用語（用法）は "新規対訳" から投稿できます。